Please Wait.....
Report
United States Clinical Trial Supplies Market By Clinical Phase (Phase I, Phase II, Phase III, Others), By Product & Services (Manufacturing, Storage & Distribution, Supply Chain Management), By Therapeutic Use (Oncology, CNS Diseases, Cardiovascular Diseases, Infectious Disease, Metabolic Disorders, Others), By End User (Pharmaceutical, Biologics, Medical device, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
Market Report I 2025-04-25 I 82 Pages I TechSci Research
Market Overview
The United States Clinical Trial Supplies Market was valued at USD 446.06 million in 2024 and is projected to reach USD 638.33 million by 2030, growing at a CAGR of 6.13% during the forecast period. Growth in the market is fueled by the rising complexity of clinical trials, particularly with the advent of personalized medicine and biologics, requiring specialized handling, storage, and distribution solutions. Demand for advanced supply chain models, including temperature-sensitive logistics and just-in-time delivery, is on the rise. The expansion of decentralized clinical trials (DCTs) further adds to logistical challenges, prompting companies to invest in digital technologies such as IoT and AI to optimize supply chain operations. While market opportunities abound, challenges persist with increasing supply chain complexity, regulatory compliance costs, and economic disruptions like inflation and raw material price fluctuations. Nonetheless, the integration of digital solutions, the expansion of clinical trial sites, and the growing focus on patient-centric models are poised to create new growth avenues for the market.
Key Market Drivers
Rising Number of Clinical Trials Across Therapeutic Areas
The steady rise in clinical trials across a broad range of therapeutic areas is a key driver of the United States Clinical Trial Supplies Market. Pharmaceutical, biotechnology, and medical device companies are significantly expanding their research and development efforts, fueled by increasing investment in innovation and the growing burden of chronic diseases such as cancer, diabetes, and cardiovascular disorders. As new therapies progress into clinical stages, there is an escalating need for efficient and specialized supply chains to support complex trial protocols, manage temperature-sensitive products, and ensure reliable delivery to global sites. Data from the World Health Organization's ICTRP highlights consistent growth in newly recruiting clinical trials across most regions, with particular momentum in South-East Asia. The rising complexity of decentralized trials and direct-to-patient models further intensifies the demand for agile and innovative supply chain strategies. As sponsors diversify therapeutic pipelines and broaden geographic footprints, clinical trial supply providers are becoming increasingly critical to ensuring the success and regulatory compliance of trials, supporting the market's expansion.
Key Market Challenges
Complexity in Managing Global Supply Chains
Managing global supply chains remains a significant hurdle for the United States Clinical Trial Supplies Market. Expanding clinical trials across multiple countries introduces operational complexities, including navigating diverse customs regulations, language requirements, and varying local timelines. Demand forecasting becomes increasingly difficult due to unpredictable patient enrollment and protocol amendments, straining inventory management. Maintaining drug stability, timely delivery, and compliance becomes even more critical for temperature-sensitive biologics and advanced therapies, often requiring costly specialized logistics. The rise of decentralized trials necessitates flexible supply models while maintaining rigorous quality standards. Adapting supply chains through the use of advanced technology and building resilient infrastructure significantly increases operational costs, putting pressure on clinical trial budgets and profitability.
Key Market Trends
Increased Adoption of Supply Chain Digitalization and Real-Time Monitoring
The adoption of supply chain digitalization and real-time monitoring is reshaping operations within the United States Clinical Trial Supplies Market. Companies are increasingly implementing digital platforms like Interactive Response Technology (IRT), cloud-based inventory systems, and IoT-enabled tracking devices to improve supply chain transparency and responsiveness. Real-time visibility into shipment progress, drug availability, and temperature control allows supply managers to proactively address potential issues, minimizing stockouts, wastage, and delays. Real-time monitoring also ensures regulatory compliance by recording key data such as temperature excursions and chain-of-custody, crucial for high-value biologics and personalized therapies. Predictive analytics further support smarter resupply strategies, optimizing trial continuity and improving patient experience. These digital advancements offer enhanced operational control, reduced risks, and improved efficiency for sponsors and supply chain partners alike.
Key Market Players
- Thermo Fisher Scientific Inc.
- Marken (UPS)
- PCI Pharma Services
- Sharp Services LLC
- Cencora, Inc.
- Myonex
- Parexel International Corporation
- IQVIA
- Novo Holdings A/S
- ICON Plc
Report Scope:
In this report, the United States Clinical Trial Supplies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- United States Clinical Trial Supplies Market, By Clinical Phase:
o Phase I
o Phase II
o Phase III
o Others
- United States Clinical Trial Supplies Market, By Product & Services:
o Manufacturing
o Storage & Distribution
o Supply Chain Management
- United States Clinical Trial Supplies Market, By Therapeutic Use:
o Oncology
o CNS Diseases
o Cardiovascular Diseases
o Infectious Disease
o Metabolic Disorders
o Others
- United States Clinical Trial Supplies Market, By End User:
o Pharmaceutical
o Biologics
o Medical Device
o Others
- United States Clinical Trial Supplies Market, By Region:
o North-East
o Mid-West
o West
o South
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the United States Clinical Trial Supplies Market.
Available Customizations:
United States Clinical Trial Supplies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. United States Clinical Trial Supplies Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Clinical Phase (Phase I, Phase II, Phase III, Others)
5.2.2. By Product & Services (Manufacturing, Storage & Distribution, Supply Chain Management)
5.2.3. By Therapeutic Use (Oncology, CNS Diseases, Cardiovascular Diseases, Infectious Disease, Metabolic Disorders, Others)
5.2.4. By End User (Pharmaceutical, Biologics, Medical device, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North-East Clinical Trial Supplies Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Clinical Phase
6.2.2. By Product & Services
6.2.3. By Therapeutic Use
6.2.4. By End User
7. Mid-West Clinical Trial Supplies Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Clinical Phase
7.2.2. By Product & Services
7.2.3. By Therapeutic Use
7.2.4. By End User
8. West Clinical Trial Supplies Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Clinical Phase
8.2.2. By Product & Services
8.2.3. By Therapeutic Use
8.2.4. By End User
9. South Clinical Trial Supplies Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Clinical Phase
9.2.2. By Product & Services
9.2.3. By Therapeutic Use
9.2.4. By End User
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Merger & Acquisition (If Any)
11.2. Product Launches (If Any)
11.3. Recent Developments
12. Policy & Regulatory Landscape
13. United States Economic Profile
14. United States Clinical Trial Supplies Market: SWOT Analysis
15. Porter's Five Forces Analysis
15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Products
16. Competitive Landscape
16.1. Thermo Fisher Scientific Inc.
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products & Services
16.1.4. Financials (As Reported)
16.1.5. Recent Developments
16.1.6. Key Personnel Details
16.1.7. SWOT Analysis
16.2. Marken (UPS)
16.3. PCI Pharma Services
16.4. Sharp Services LLC
16.5. Cencora, Inc.
16.6. Myonex
16.7. Parexel International Corporation
16.8. IQVIA
16.9. Novo Holdings A/S
16.10. ICON Plc
17. Strategic Recommendations
18. About Us & Disclaimer
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security